Bellicum Pharmaceuticals, Inc. Stock OTC Markets
Equities
BLCM
US0794814048
Biotechnology & Medical Research
Sales 2021 | 6.2M 8.46M | Sales 2022 | 1.5M 2.05M | Capitalization | 822K 1.12M |
---|---|---|---|---|---|
Net income 2021 | -9M -12.28M | Net income 2022 | -25M -34.12M | EV / Sales 2021 * | - |
Net cash position 2021 * | - 0 | Net cash position 2022 * | - 0 | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | 13 |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 98.45% |
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-12.15% | 22.34B | |
-2.79% | 21.93B | |
-6.13% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |